Reduced BMP signaling is a pathological finding in PAH, and the downregulation of SMURF1 stimulates BMP signaling by inhibiting BMPR2 degradation in vitro and in preclinical models [167]. This evidence concerns the gene SMURF1 and pulmonary arterial hypertension.